These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23776363)

  • 1. The genetics of breast cancer: risk factors for disease.
    Collins A; Politopoulos I
    Appl Clin Genet; 2011; 4():11-9. PubMed ID: 23776363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
    Gracia-Aznarez FJ; Fernandez V; Pita G; Peterlongo P; Dominguez O; de la Hoya M; Duran M; Osorio A; Moreno L; Gonzalez-Neira A; Rosa-Rosa JM; Sinilnikova O; Mazoyer S; Hopper J; Lazaro C; Southey M; Odefrey F; Manoukian S; Catucci I; Caldes T; Lynch HT; Hilbers FS; van Asperen CJ; Vasen HF; Goldgar D; Radice P; Devilee P; Benitez J
    PLoS One; 2013; 8(2):e55681. PubMed ID: 23409019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
    Dumont M; Weber-Lassalle N; Joly-Beauparlant C; Ernst C; Droit A; Feng BJ; Dubois S; Collin-Deschesnes AC; Soucy P; Vallée M; Fournier F; Lemaçon A; Adank MA; Allen J; Altmüller J; Arnold N; Ausems MGEM; Berutti R; Bolla MK; Bull S; Carvalho S; Cornelissen S; Dufault MR; Dunning AM; Engel C; Gehrig A; Geurts-Giele WRR; Gieger C; Green J; Hackmann K; Helmy M; Hentschel J; Hogervorst FBL; Hollestelle A; Hooning MJ; Horváth J; Ikram MA; Kaulfuß S; Keeman R; Kuang D; Luccarini C; Maier W; Martens JWM; Niederacher D; Nürnberg P; Ott CE; Peters A; Pharoah PDP; Ramirez A; Ramser J; Riedel-Heller S; Schmidt G; Shah M; Scherer M; Stäbler A; Strom TM; Sutter C; Thiele H; van Asperen CJ; van der Kolk L; van der Luijt RB; Volk AE; Wagner M; Waisfisz Q; Wang Q; Wang-Gohrke S; Weber BHF; Genome Of The Netherlands Project ; Ghs Study Group ; Devilee P; Tavtigian S; Bader GD; Meindl A; Goldgar DE; Andrulis IL; Schmutzler RK; Easton DF; Schmidt MK; Hahnen E; Simard J
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited mutations in breast cancer genes--risk and response.
    Shuen AY; Foulkes WD
    J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):3-15. PubMed ID: 21461995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.
    Guglielmi C; Scarpitta R; Gambino G; Conti E; Bellè F; Tancredi M; Cervelli T; Falaschi E; Cosini C; Aretini P; Congregati C; Marino M; Patruno M; Pilato B; Spina F; Balestrino L; Tenedini E; Carnevali I; Cortesi L; Tagliafico E; Tibiletti MG; Tommasi S; Ghilli M; Vivanet C; Galli A; Caligo MA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    Aloraifi F; Boland MR; Green AJ; Geraghty JG
    Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
    Riedlova P; Janoutova J; Hermanova B
    Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GENOME-WIDE ASSOCIATION MAPPING AND RARE ALLELES: FROM POPULATION GENOMICS TO PERSONALIZED MEDICINE - Session Introduction.
    DE LA Vega FM; Bustamante CD; Leal SM
    Pac Symp Biocomput; 2011; ():74-5. PubMed ID: 21121034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
    El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
    BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women.
    Sepahi I; Faust U; Sturm M; Bosse K; Kehrer M; Heinrich T; Grundman-Hauser K; Bauer P; Ossowski S; Susak H; Varon R; Schröck E; Niederacher D; Auber B; Sutter C; Arnold N; Hahnen E; Dworniczak B; Wang-Gorke S; Gehrig A; Weber BHF; Engel C; Lemke JR; Hartkopf A; Nguyen HP; Riess O; Schroeder C
    BMC Cancer; 2019 Aug; 19(1):787. PubMed ID: 31395037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into breast cancer genetics and impact on patient management.
    Rosman DS; Kaklamani V; Pasche B
    Curr Treat Options Oncol; 2007 Feb; 8(1):61-73. PubMed ID: 17634833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Other" breast cancer susceptibility genes: searching for more holy grail.
    Nathanson KL; Weber BL
    Hum Mol Genet; 2001 Apr; 10(7):715-20. PubMed ID: 11257104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
    Aloraifi F; McDevitt T; Martiniano R; McGreevy J; McLaughlin R; Egan CM; Cody N; Meany M; Kenny E; Green AJ; Bradley DG; Geraghty JG; Bracken AP
    FEBS J; 2015 Sep; 282(17):3424-37. PubMed ID: 26094658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
    Anglian Breast Cancer Study Group
    Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.